 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Recro Pharma Inc. (REPH)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-17 Purchase | 2019-05-21 4:11 pm | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 40,000 | $9 | $360,000 | 1,104,546 (Direct Indirect) | View |
| 2019-05-13 Sale | 2019-05-15 4:06 pm | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 144,806 | $8.89 | $1,287,296 | 342,947 (Indirect Direct) | View |
| 2018-05-24 Sale | 2018-05-24 5:02 pm | Recro Pharma Inc. | REPH | Broadfin Healthcare Master Fund Ltd Broadfin Capital LLC KOTLER KEVIN 10% Owner | 188,000 | $5.815 | $1,093,182 | 2,206,725 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-12-05 Option Award | 2019-12-09 6:43 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 17,283 | $0 | 48,812 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:42 pm | N/A N/A | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 13,848 | $0 | 41,260 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:38 pm | N/A N/A | Recro Pharma Inc. | REPH | Ashton William Director | 17,582 | $0 | 44,994 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:37 pm | N/A N/A | Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director | 15,284 | $0 | 44,196 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:35 pm | N/A N/A | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 15,284 | $0 | 42,696 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:29 pm | N/A N/A | Recro Pharma Inc. | REPH | Reasons Bryan M. Director | 9,156 | $0 | 32,143 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:28 pm | N/A N/A | Recro Pharma Inc. | REPH | Weisman Wayne Director | 15,284 | $0 | 49,696 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:27 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 93,550 | $0 | 246,691 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:25 pm | N/A N/A | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 7,439 | $0 | 1,104,546 (Direct) | View |
| 2019-11-21 Other | 2019-11-22 5:03 pm | N/A N/A | Baudax Bio Inc. | BXRX | Recro Pharma Inc. 10% Owner | 9,211,145 | $0 | 9,211,245 (Direct) | View |
| 2019-11-21 Other | 2019-11-22 5:03 pm | N/A N/A | Baudax Bio Inc. | BXRX | Recro Pharma Inc. 10% Owner | 9,211,245 | $0 | 9,211,245 (Direct) | View |
| 2019-06-05 Exercise | 2019-06-07 5:19 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 32,248 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 5:19 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 719 | $9.55 | 32,248 (Direct) | View |
| 2019-06-05 Exercise | 2019-06-07 5:19 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 32,248 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:06 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 123,500 | $2.47 | 342,947 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:06 pm | N/A 2024-12-17 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 123,500 | $2.47 | 342,947 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-13 10:43 am | N/A N/A | Recro Pharma Inc. | REPH | Flynn Karen Director | 7,955 | $0 | 28,212 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-13 10:43 am | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Flynn Karen Director | 10,888 | $8.8 | 28,212 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:28 pm | N/A N/A | Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director | 7,955 | $0 | 28,912 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:28 pm | N/A 2029-05-09 | Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director | 10,888 | $8.8 | 28,912 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:27 pm | N/A N/A | Recro Pharma Inc. | REPH | Ashton William Director | 7,955 | $0 | 27,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:27 pm | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Ashton William Director | 10,888 | $8.8 | 27,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:27 pm | N/A N/A | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 7,955 | $0 | 27,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:27 pm | N/A 2029-05-09 | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 10,888 | $8.8 | 27,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:26 pm | N/A N/A | Recro Pharma Inc. | REPH | Weisman Wayne Director | 7,955 | $0 | 34,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:26 pm | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Weisman Wayne Director | 10,888 | $8.8 | 34,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:25 pm | N/A N/A | Recro Pharma Inc. | REPH | Reasons Bryan M. Director | 7,955 | $0 | 22,987 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:25 pm | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Reasons Bryan M. Director | 10,888 | $8.8 | 22,987 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:25 pm | N/A N/A | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 7,955 | $0 | 27,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:25 pm | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 10,888 | $8.8 | 27,412 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:24 pm | N/A N/A | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 7,955 | $0 | 1,064,546 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 4:24 pm | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 10,888 | $8.8 | 1,064,546 (Direct) | View |
| 2019-03-25 Option Award | 2019-03-27 5:44 pm | N/A 2029-03-25 | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 20,000 | $6.41 | 20,000 (Direct) | View |
| 2019-01-18 Option Award | 2019-02-19 4:12 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 12,857 | $0 | 60,000 (Direct) | View |
| 2019-01-18 Option Award | 2019-02-19 4:12 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 5,750 | $0 | 60,000 (Direct) | View |
| 2019-01-18 Tax Withholding | 2019-02-19 4:12 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 1,880 | $7.99 | 60,000 (Direct) | View |
| 2019-01-18 Option Award | 2019-02-19 4:12 pm | N/A 2029-01-18 | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 60,000 | $7.99 | 60,000 (Direct) | View |
| 2019-01-18 Option Award | 2019-02-19 4:12 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 14,464 | $0 | 67,500 (Direct) | View |
| 2019-01-18 Exercise | 2019-02-19 4:12 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 6,400 | $0 | 67,500 (Direct) | View |
| 2019-01-18 Tax Withholding | 2019-02-19 4:12 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 1,782 | $7.99 | 67,500 (Direct) | View |
| 2019-01-18 Option Award | 2019-02-19 4:12 pm | N/A 2029-01-18 | Recro Pharma Inc. | REPH | Celano Michael COO | 67,500 | $7.99 | 67,500 (Direct) | View |
| 2019-01-18 Exercise | 2019-02-19 4:12 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 6,400 | $0 | 67,500 (Direct) | View |
| 2019-01-18 Option Award | 2019-02-19 4:11 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 40,864 | $0 | 220,872 (Direct) | View |
| 2019-01-18 Exercise | 2019-02-19 4:11 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 5,000 | $0 | 220,872 (Direct) | View |
| 2019-01-18 Tax Withholding | 2019-02-19 4:11 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 1,425 | $7.99 | 220,872 (Direct) | View |
| 2019-01-18 Option Award | 2019-02-19 4:11 pm | N/A 2029-01-18 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 190,700 | $7.99 | 220,872 (Direct) | View |
| 2019-01-18 Exercise | 2019-02-19 4:11 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 5,000 | $0 | 220,872 (Direct) | View |
| 2019-01-18 Option Award | 2019-01-23 4:08 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 35,801 | $0 | 215,809 (Direct) | View |
| 2019-01-18 Exercise | 2019-01-23 4:08 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 5,000 | $0 | 215,809 (Direct) | View |
| 2019-01-18 Tax Withholding | 2019-01-23 4:08 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 1,425 | $7.99 | 215,809 (Direct) | View |
| 2019-01-18 Option Award | 2019-01-23 4:08 pm | N/A 2029-01-18 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 171,184 | $7.99 | 215,809 (Direct) | View |
| 2019-01-18 Exercise | 2019-01-23 4:08 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 5,000 | $0 | 215,809 (Direct) | View |
| 2019-01-18 Option Award | 2019-01-23 4:06 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 12,672 | $0 | 60,592 (Direct) | View |
| 2019-01-18 Exercise | 2019-01-23 4:06 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 6,400 | $0 | 60,592 (Direct) | View |
| 2019-01-18 Tax Withholding | 2019-01-23 4:06 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 1,782 | $7.99 | 60,592 (Direct) | View |
| 2019-01-18 Option Award | 2019-01-23 4:06 pm | N/A 2029-01-18 | Recro Pharma Inc. | REPH | Celano Michael COO | 60,592 | $7.99 | 60,592 (Direct) | View |
| 2019-01-18 Exercise | 2019-01-23 4:06 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 6,400 | $0 | 60,592 (Direct) | View |
| 2019-01-18 Option Award | 2019-01-23 4:05 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 11,264 | $0 | 53,859 (Direct) | View |
| 2019-01-18 Option Award | 2019-01-23 4:05 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 5,750 | $0 | 53,859 (Direct) | View |
| 2019-01-18 Tax Withholding | 2019-01-23 4:05 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 1,880 | $7.99 | 53,859 (Direct) | View |
| 2019-01-18 Option Award | 2019-01-23 4:05 pm | N/A 2029-01-18 | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 53,859 | $7.99 | 53,859 (Direct) | View |
| 2019-01-02 Tax Withholding | 2019-01-04 6:28 pm | N/A N/A | Recro Pharma Inc. | REPH | Celano Michael COO | 1,702 | $7.41 | 26,773 (Direct) | View |
| 2019-01-02 Tax Withholding | 2019-01-04 5:39 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 979 | $7.41 | 13,021 (Direct) | View |
| 2019-01-02 Tax Withholding | 2019-01-04 5:37 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 4,223 | $7.41 | 175,008 (Direct) | View |
| 2019-01-02 Tax Withholding | 2019-01-04 4:40 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 4,223 | $7.41 | 175,008 (Direct) | View |
| 2019-01-02 Tax Withholding | 2019-01-04 4:37 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 979 | $7.41 | 13,021 (Direct) | View |
| 2018-06-05 Exercise | 2018-06-07 4:33 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 14,000 (Direct) | View |
| 2018-06-05 Exercise | 2018-06-07 4:33 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 14,000 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:57 pm | N/A N/A | Recro Pharma Inc. | REPH | Ashton William Director | 13,274 | $0 | 19,457 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:57 pm | N/A N/A | Recro Pharma Inc. | REPH | Ashton William Director | 13,274 | $0 | 19,457 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:55 pm | N/A N/A | Recro Pharma Inc. | REPH | Flynn Karen Director | 13,274 | $0 | 20,257 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:55 pm | N/A N/A | Recro Pharma Inc. | REPH | Flynn Karen Director | 13,274 | $0 | 20,257 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:54 pm | N/A N/A | Recro Pharma Inc. | REPH | Weisman Wayne Director | 13,274 | $0 | 26,457 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:54 pm | N/A N/A | Recro Pharma Inc. | REPH | Weisman Wayne Director | 13,274 | $0 | 26,457 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:53 pm | N/A N/A | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 13,274 | $0 | 19,457 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:53 pm | N/A N/A | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 13,274 | $0 | 19,457 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:51 pm | N/A N/A | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 13,274 | $0 | 19,457 (Direct) | View |
| 2018-05-12 Exercise | 2018-05-14 4:51 pm | N/A N/A | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 13,274 | $0 | 19,457 (Direct) | View |